ApprovalTrail

Approval · Notice of Compliance 9486 · 2008

RABAVERT: Notice of Compliance 9486

Issued April 11, 2008

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
9486
Date
April 11, 2008
Product type
Biologic
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Changes in manufacturing process
Therapeutic class
Active immunizing agent

Products in this notice

BrandDINStatus today
RABAVERTNot yet assigned—

Medicinal ingredients